The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from CNW Group

Patheon Announces Date of Fiscal 2013 Third Quarter Financial Results

Wednesday, August 21, 2013

Patheon Announces Date of Fiscal 2013 Third Quarter Financial Results

07:00 EDT Wednesday, August 21, 2013

TORONTO, Aug. 21, 2013 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, announced today that it will report its fiscal 2013 third quarter financial results on Thursday, September 5, 2013.

In conjunction with the company's financial results announcement, Patheon will host a conference call and webcast on Thursday, September 5, 2013, at 10 a.m. Eastern Time. The financial results news release will be issued at approximately 7 a.m. Eastern Time on Thursday, September 5, 2013.

Interested parties are invited to access the conference call, via telephone, in listen-only mode, toll-free at 1-888-231-8191 (U.S., including Puerto Rico) and 1-647-427-7450 (Canada and international). Listeners are encouraged to dial in five to fifteen minutes in advance to avoid delays.  Slides will also be available for viewing during the call by accessing http://ir.patheon.com/events.cfm.

A telephone replay of the conference call will be available between Thursday, September 5, 2013 and Thursday, September 12, 2013 by dialing 1-855-859-2056 (toll-free) or 1-403-451-9481, and by entering identification number 29239924, followed by the number key.  The webcast and slides will be archived at http://ir.patheon.com/events.cfm.

About Patheon Inc.

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms.  Through the company's recent acquisition of Banner Pharmacaps - a market leader in soft gelatin capsule technology - Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies.  The company's integrated network consists of 17 locations, including 13 commercial contract manufacturing facilities and 8 development centers across North America and Europe.  Patheon enables customer products to be launched with confidence anywhere in the world.  For more information visit www.patheon.com.

SOURCE: Patheon Inc.

For further information:

Patheon Inc.
919 226 3200
investorrelations@patheon.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections